联合肝叶切除术治疗肝门部胆管癌的疗效观察  

Clinical observation of Joint lobe rescction for treatment ofhilar bile duct carcinoma

作　　者：贾瑾堂[1] 刘一帆[2] 米秦宇 许钧[3] 

机构地区：[1]兰州市第二人民医院普外三科,甘肃兰州730046 [2]兰州大学第二医院内分泌代谢科,甘肃兰州730030 [3]兰州市第二人民医院中西科,甘肃兰州730046

出　　处：《医药前沿》2015年第31期23-25,共3页Journal of Frontiers of Medicine

摘　　要：目的：分析研究联合肝叶切除术进行肝门部胆管瘤治疗的临床效果。方法：选取我院自2012年1月至2014年1月收治的62例经联合肝叶切除术治疗的肝门部胆管瘤患者作为研究对象，采用回顾分析法，对患者的临床资料与治疗效果进行总结分析。结果：62例患者中，1例发生死亡，患者手术治疗的并发症发生率约为37％，手术治疗平均生存时间为（32．4±11．2）个月，在对于患者术后1、3、5年的随访调查中显示，患者存活率分别达到79％、48％和29％，治疗效果突出。结论：联合肝叶切除术进行肝门部胆管瘤治疗能够有效延长患者存活时间，减少患者手术治疗并发症，值得临床推广和应用。Objective To study joint lobe resection for the hepatic bile duct carcinoma treatment. Methods Selection Fro m January 2012 to January 2014, 62 patients with the joint lobe resection of the hepatic bile duct carcinoma as the research object, retrospective analysis, summarized the clinical data of patients. Results In 62 cases of patients, I case death, surgical treatment of patients with complications is about 37%, surgery average survival time was （32.4 ＋ 11.2） months, postoperative patients with for 1, 3 and 5years of follow-up survey, patients survival rate reached 79%, 48% and 29% respectively, treatment effect is prominent. Conclusion Combined lobe resection for hepatic bile duct portal vein tumor treatment can effectively extend the survival time of patients, reduce the surgical treatment for patients with complications, worthy of clinical popularization and application.

关 键 词：联合肝叶切除术 肝门部胆管瘤 疗效观察 

分 类 号：R730.5[医药卫生—肿瘤]